LIVN - LivaNova PLC
IEX Last Trade
50.34
0.100 0.199%
Share volume: 678,289
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$50.24
0.10
0.20%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-02 | 2023-02-27 | 2023-05-03 | 2023-07-26 | 2023-11-01 | 2024-02-29 | 2024-05-03 | 2024-08-01 | |
| Assets | |||||||||
| Total Assets | 2.213 B | 2.295 B | 2.295 B | 2.342 B | 2.329 B | 2.430 B | 2.460 B | 2.453 B | |
| Current Assets | 851.222 M | 886.136 M | 903.017 M | 941.835 M | 953.867 M | 988.158 M | 1.040 B | 1.047 B | |
| Inventories | 122.041 M | 129.379 M | 142.453 M | 156.446 M | 161.539 M | 147.887 M | 153.176 M | 154.722 M | |
| Other Current Assets | 50.809 M | 58.029 M | 59.288 M | 65.148 M | 69.735 M | 47.327 M | 61.727 M | 57.957 M | |
| Short Term Investments | 50.809 M | 58.029 M | 59.288 M | 65.148 M | 69.735 M | 47.327 M | 61.727 M | 57.957 M | |
| Total Receivables | 172.093 M | 183.110 M | 178.318 M | 185.881 M | 189.871 M | 215.072 M | 209.431 M | 200.889 M | |
| Current Cash | 231.114 M | 214.172 M | 214.340 M | 222.935 M | 233.941 M | 266.504 M | 309.191 M | 329.237 M | |
| Total Non-current Assets | 1.362 B | 1.409 B | 1.392 B | 1.400 B | 1.376 B | 1.441 B | 1.420 B | 1.406 B | |
| Property Plant Equipment | 139.162 M | 147.187 M | 149.060 M | 149.568 M | 149.302 M | 154.181 M | 152.237 M | 158.055 M | |
| Other Assets | 64.766 M | 70.624 M | 44.965 M | 55.512 M | 55.784 M | 50.559 M | 54.982 M | 53.916 M | |
| Intangible Assets | 365.026 M | 368.559 M | 364.056 M | 357.420 M | 347.672 M | 261.178 M | 253.927 M | 248.195 M | |
| Goodwill | 742.370 M | 768.787 M | 774.447 M | 779.212 M | 767.055 M | 782.941 M | 771.817 M | 766.368 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 2.213 B | 2.295 B | 2.295 B | 2.342 B | 2.329 B | 2.430 B | 2.460 B | 2.453 B | |
| Total liabilities | 1.066 B | 1.087 B | 1.068 B | 1.101 B | 1.104 B | 1.152 B | 1.238 B | 1.211 B | |
| Total current liabilities | 288.016 M | 297.398 M | 316.129 M | 288.164 M | 295.396 M | 334.983 M | 327.771 M | 302.986 M | |
| Accounts Payable | 69.616 M | 74.310 M | 75.730 M | 78.212 M | 62.780 M | 80.845 M | 75.944 M | 81.323 M | |
| Other liabilities | 224.889 M | 233.620 M | 193.808 M | 208.679 M | 205.265 M | 191.454 M | 250.843 M | 247.874 M | |
| Current long term debt | 21.695 M | 23.434 M | 22.297 M | 19.074 M | 19.027 M | 18.111 M | 19.704 M | 19.742 M | |
| Long term debt | 518.249 M | 518.067 M | 520.201 M | 567.951 M | 568.163 M | 568.543 M | 604.753 M | 605.432 M | |
| Other liabilities | 224.889 M | 233.620 M | 193.808 M | 208.679 M | 205.265 M | 191.454 M | 250.843 M | 247.874 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 1.147 B | 1.208 B | 1.227 B | 1.241 B | 1.225 B | 1.278 B | 1.222 B | 1.243 B | |
| Common stock | 53.534 M | 53.548 M | 53.617 M | 53.803 M | 53.989 M | 54.347 M | 54.008 M | 54.238 M | |
| Retained earnings | -985.691 M | -984.030 M | -976.660 M | -975.505 M | -982.823 M | -966.484 M | -1.008 B | -992.094 M |